6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	SFG Quarterly Activities/Appendix 4CCash Flow Report
Just now	BSA Announces On-Market Share Buy-Back
Just now	Placement
Just now	Q3 FY26 Activities Report and Appendix 4C
Just now	FY26 Q1 Quarterly Activities Report and Appendix 4C

About

Kiora Pharmaceuticals Inc (NASDAQ:KPRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway

Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline

Kiora Pharmaceuticals Announces Private Placement for Up to $24 Million Led by Perceptive Advisors

Kiora Pharmaceuticals Announces Management Team Changes

Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with Two Active Phase 2 Clinical Trials

Financials

Revenue

$0

Market Cap

$7.66 M

EPS

-2.64

Community Chat

Ask AI